Alzheimer’s Cure, Not if , it’s when
Roskamp Institute director Michael Mullan says he believes that eventually drugs will be added together like a cocktail, similar to the way HIV or cancer is treated. Mullan originally began administering Nilvadipine to Alzheimer’s patients in Ireland. Nilvadipine, which was already approved for the treatment of hypertension in Europe, has been shown to stop production of Amyloid proteins. Mullan, who led a team of researchers in the discovery of the buildup of Amyloid proteins that causes Alzheimer’s disease, says that Nilvadipine stops the body from making Amyloid.
Michael Mullan - publications
Michael Mullan, director of the prestigious Roskamp Institute in Florida, is a productive researcher with over 200 research papers published in prominent international medical journals. Amongst the numerous studies available, Michael Mullan is recognized for the quantity of research that he has made available by writing educational articles on the topic of Alzheimer’s disease and for his contribution to the significant distribution of awareness of this destructive disease. Family members and others can educate themselves on Alzheimer’s and gain an understanding of the disease in order to help the sufferers by going over the topics in Mullan’s informative publications.